She loves me – she loves me not
Just like this classic paradox, many of us with RA have the same love/hate relationship with the corticosteroids we often have little choice but to take to keep our RA under control. For many of us it is the one medication that will put a halt (or at least give some measure of relief) to a flare. Sadly there are not a lot of options that serve this purpose.
How much more important can it get when you cannot function or sleep or enjoy life when the pain of a flare takes over your life? Yet there seems to be little useful research out there on this and sadly and certainly no viable options or substitutes for corticosteroids from my viewpoint.
Despite some wonderful and upcoming medications in the pipeline from a DMARD (Disease Modifying Anti-Rheumatic Drug) perspective there is nothing much to report in the NSAID (non steroidal anti inflammatory drug) category…which is where we need some help! There has not been anything new in this arena since the Cox2 inhibitors which turned out to be a bust since their proposed benefits were not what they were purported to be. I wonder if that has not been part of why little has been done from a research perspective. That said, the pronounced negative side effects of long term use of corticosteroids is well known and not very pretty… I have experience with most of them including easy bruising and rash..just one of many.
Bone loss issues are surely another very serious one and last year I was diagnosed as having osteoporosis and now take annual infusions of Reclast to counter that problem.
There are many, many more negative and serious side effects. The list is long and can be found by doing a simple web search. Ironically there is a place for the use of corticosteroids in the treatment of RA:
The issue comes in when one stays on it for extended periods which often happens as a result of our own adrenal gland not being able to “start up” the natural form our bodies produce after years of using the synthetic version. That seems to be where I am at currently. I have had RA since 1996 and over the years, used many, many medications to treat the disease. Once the DMARDS, now biologics for me, became less effective about 10 years ago, I was unable to completely halt the use of prednisone without suffering intense flaring and all the fun components that go with it.
I am currently trying to get down from 4mg to 2mg and have used the method of “rocking” between 4 and 2 with a strict schedule of alternating. The problem is that in the interim I had some work to do that meant heavy use of my wrists and shoulders and so sadly I flared really intensely and despite suffering through three weeks I could not get it to settle down without doing a burst of prednisone to get it back under control. Not sure if it is going to work at all at this point. No sooner do I settle on a plan to wean off of it then something comes along to make it a challenge….life…the daily kind…enters into it and makes the process almost impossible.
Not sure where it will go at this point. Thus the reason I so wish that more research was being done in this area. I understand that DMARDS are often successfully blocking joint erosions but that does not take care of all the components of managing RA, particularly the pain and intensity of flaring joints. I cannot and will not take any pain medications for a variety of reasons so new and less harmful alternatives to corticosteroids is crucial and should be advocated for by everyone connected with arthritis. We also need to make it clear to our physicians what we are going through so that they understand the complexity and seriousness of this issue.
I remain hopeful despite my own frustrating experience that an alternative can be developed…I just hope it happens before the negative side effects become too serious.
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The RheumatoidArthritis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.